274 related articles for article (PubMed ID: 36167386)
1. Comparative cardiovascular side effects of medications for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
Lannes A; Farhat LC; Del Giovane C; Cipriani A; Revet A; Cortese S
BMJ Open; 2022 Sep; 12(9):e062748. PubMed ID: 36167386
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D;
BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systematic review and network meta-analysis.
Cortese S; Del Giovane C; Chamberlain S; Philipsen A; Young S; Bilbow A; Cipriani A
BMJ Open; 2022 Mar; 12(3):e058102. PubMed ID: 35277411
[TBL] [Abstract][Full Text] [Related]
5. Effects of neurofeedback versus methylphenidate for the treatment of attention-deficit/hyperactivity disorder protocol for a systematic review and meta-analysis of head-to-head trials.
Yan L; Zhang J; Yuan Y; Cortese S
Medicine (Baltimore); 2018 Sep; 97(39):e12623. PubMed ID: 30278582
[TBL] [Abstract][Full Text] [Related]
6. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J; Castells X; Ehimare UP; Smith CH
Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
[TBL] [Abstract][Full Text] [Related]
7. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
[TBL] [Abstract][Full Text] [Related]
9. Are ADHD medications under or over prescribed worldwide?: Protocol for a systematic review and meta-analysis.
Moreira-Maia CR; Massuti R; Tessari L; Campani F; Akutagava-Martins GC; Cortese S; Rohde LA
Medicine (Baltimore); 2018 Jun; 97(24):e10923. PubMed ID: 29901582
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Elliott J; Johnston A; Husereau D; Kelly SE; Eagles C; Charach A; Hsieh SC; Bai Z; Hossain A; Skidmore B; Tsakonas E; Chojecki D; Mamdani M; Wells GA
PLoS One; 2020; 15(10):e0240584. PubMed ID: 33085721
[TBL] [Abstract][Full Text] [Related]
11. Dismantling cognitive-behavioural therapy components for attention-deficit hyperactivity disorder in adolescents and adults: protocol for a network meta-analysis.
Hamatani S; Matsumoto K; Kunisato Y; Okawa S; Yamashita M; Mizuno Y
BMJ Open; 2023 Apr; 13(4):e068547. PubMed ID: 37076162
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and acceptability of psychosocial treatments for disruptive behaviour disorders in children and adolescents: study protocol for a systematic review and network meta-analysis.
Zhang L; Ren Z; Ma X; Hazer-Rau D; Jiang G; Zhao C; Zhao Z; Liu Q; Yuan F
BMJ Open; 2021 Jun; 11(6):e046091. PubMed ID: 34187820
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of obesity in attention-deficit/hyperactivity disorder: study protocol for a systematic review and meta-analysis.
Cortese S; Moreira Maia CR; Rohde LA; Morcillo-Peñalver C; Faraone SV
BMJ Open; 2014 Mar; 4(3):e004541. PubMed ID: 24643169
[TBL] [Abstract][Full Text] [Related]
14. Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis.
Radonjić NV; Bellato A; Khoury NM; Cortese S; Faraone SV
CNS Drugs; 2023 May; 37(5):381-397. PubMed ID: 37166701
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy in paediatric type 2 diabetes mellitus: a protocol for a systematic review and network meta-analysis of randomised trials.
Zhou F; Deng J; Banfield L; Thabane L; Sadeghirad B; Samaan MC
BMJ Open; 2022 Sep; 12(9):e065287. PubMed ID: 36167361
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.
Catalá-López F; Ridao M; Núñez-Beltrán A; Gènova-Maleras R; Alonso-Arroyo A; Aleixandre-Benavent R; Catalá MA; Tabarés-Seisdedos R
Syst Rev; 2019 Feb; 8(1):49. PubMed ID: 30744675
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
[TBL] [Abstract][Full Text] [Related]
19. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
Castells X; Blanco-Silvente L; Cunill R
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
[TBL] [Abstract][Full Text] [Related]
20. Treatment of attention-deficit/hyperactivity disorder.
Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
